663 related articles for article (PubMed ID: 18414753)
101. Trans titanium(IV) complexes of salen ligands exhibit high antitumor activity.
Tzubery A; Tshuva EY
Inorg Chem; 2011 Sep; 50(17):7946-8. PubMed ID: 21797239
[TBL] [Abstract][Full Text] [Related]
102. Copper(I) halide complexes of 5-carbethoxy-2-thiouracil: synthesis, structure and in vitro cytotoxicity.
Papazoglou I; Cox PJ; Hatzidimitriou AG; Kokotidou C; Choli-Papadopoulou T; Aslanidis P
Eur J Med Chem; 2014 May; 78():383-91. PubMed ID: 24704611
[TBL] [Abstract][Full Text] [Related]
103. Antitumoral activity of non-platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2005 Dec; 48(25):7925-31. PubMed ID: 16335917
[TBL] [Abstract][Full Text] [Related]
104. Potent anticancer activity of pyrrolidine dithiocarbamate-copper complex against cisplatin-resistant neuroblastoma cells.
Zhang H; Wu JS; Peng F
Anticancer Drugs; 2008 Feb; 19(2):125-32. PubMed ID: 18176108
[TBL] [Abstract][Full Text] [Related]
105. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
[TBL] [Abstract][Full Text] [Related]
106. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
107. Synthesis and structures of group 11 metal triazenide complexes: ligand supported metallophilic interactions.
Johnson AL; Willcocks AM; Richards SP
Inorg Chem; 2009 Sep; 48(17):8613-22. PubMed ID: 19637866
[TBL] [Abstract][Full Text] [Related]
108. Cytotoxic activity of new neodymium (III) complexes of bis-coumarins.
Kostova I; Manolov I; Momekov G
Eur J Med Chem; 2004 Sep; 39(9):765-75. PubMed ID: 15337289
[TBL] [Abstract][Full Text] [Related]
109. Group 11 complexes with unsymmetrical P,S and P,Se disubstituted ferrocene ligands.
Aguado JE; Canales S; Gimeno MC; Jones PG; Laguna A; Villacampa MD
Dalton Trans; 2005 Sep; (18):3005-15. PubMed ID: 16127494
[TBL] [Abstract][Full Text] [Related]
110. A new class of (mu-eta2:eta2-disulfido)dicopper complexes: synthesis, characterization, and disulfido exchange.
Brown EC; Aboelella NW; Reynolds AM; Aullón G; Alvarez S; Tolman WB
Inorg Chem; 2004 May; 43(11):3335-7. PubMed ID: 15154793
[TBL] [Abstract][Full Text] [Related]
111. Ovarian cancer activity of cyclic amine and thiaether metal complexes.
Medvetz DA; Stakleff KD; Schreiber T; Custer PD; Hindi K; Panzner MJ; Blanco DD; Taschner MJ; Tessier CA; Youngs WJ
J Med Chem; 2007 Apr; 50(7):1703-6. PubMed ID: 17343369
[TBL] [Abstract][Full Text] [Related]
112. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
[TBL] [Abstract][Full Text] [Related]
113. Isatin-Schiff base copper(II) complexes and their influence on cellular viability.
Cerchiaro G; Aquilano K; Filomeni G; Rotilio G; Ciriolo MR; Ferreira AM
J Inorg Biochem; 2005 Jul; 99(7):1433-40. PubMed ID: 15878622
[TBL] [Abstract][Full Text] [Related]
114. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
115. Synthesis, characterization and reactivity of heteroleptic rare earth metal bis(phenolate) complexes.
Qi R; Liu B; Xu X; Yang Z; Yao Y; Zhang Y; Shen Q
Dalton Trans; 2008 Oct; (37):5016-24. PubMed ID: 18802614
[TBL] [Abstract][Full Text] [Related]
116. Cytotoxic activity of new cerium (III) complexes of bis-coumarins.
Kostova I; Manolov I; Momekov G; Tzanova T; Konstantinov S; Karaivanova M
Eur J Med Chem; 2005 Dec; 40(12):1246-54. PubMed ID: 16143428
[TBL] [Abstract][Full Text] [Related]
117. Synthesis, characterization, and in vitro evaluation of a potentially selective anticancer, mixed-metal [ruthenium(III)-platinum(II)] trinuclear complex.
Herman A; Tanski JM; Tibbetts MF; Anderson CM
Inorg Chem; 2008 Jan; 47(1):274-80. PubMed ID: 18062685
[TBL] [Abstract][Full Text] [Related]
118. Self-assembly and cytotoxicity study of waterwheel-like dinuclear metal complexes: the first metal complexes appended with multiple free hydroxamic acid groups.
Wang WH; Liu WS; Wang YW; Li Y; Zheng LF; Wang DQ
J Inorg Biochem; 2007 Feb; 101(2):297-304. PubMed ID: 17125839
[TBL] [Abstract][Full Text] [Related]
119. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
[TBL] [Abstract][Full Text] [Related]
120. Metal-NHC complexes: a survey of anti-cancer properties.
Teyssot ML; Jarrousse AS; Manin M; Chevry A; Roche S; Norre F; Beaudoin C; Morel L; Boyer D; Mahiou R; Gautier A
Dalton Trans; 2009 Sep; (35):6894-902. PubMed ID: 20449127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
